Cryptogenic organizing pneumonia - Characteristics of relapses in a series of 48 patients

被引:183
作者
Lazor, R
Vandevenne, A
Pelletier, A
Leclerc, P
Court-Fortune, I
Cordier, JF
机构
[1] Univ Lyon 1, Serv Pneumol, Hop Cardiovasc & Pneumol Louis Pradel, Ctr Etud & Rech Malad Orphelines Pulm,Hospices Ci, F-69364 Lyon 03, France
[2] CHU Strasbourg, Hop Hautepierre, Serv Pneumol, F-67000 Strasbourg, France
[3] Clin St Laurent, Serv Pneumol, Rennes, France
[4] Ctr Hosp Prive Yvelines, Serv Pneumol, Sartrouville, France
[5] CHU St Etienne, Hop Nord, Serv Pneumol, St Etienne, France
[6] Hop Cardiovasc & Pneumol Louis Pradel, Hospices Civils Lyon, Serv Pneumol, Lyon, France
关键词
D O I
10.1164/ajrccm.162.2.9909015
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Cryptogenic organizing pneumonia (COP) is a clinicopathologic syndrome characterized by rapid resolution with corticosteroids, but frequent relapses when treatment is tapered or stopped. We retrospectively studied relapses in 48 cases of biopsy-proven COP. One or more relapses (mean 2.4 +/- 2.2) occurred in 58%. At first relapse, 68% of patients were still under treatment for the initial episode. Compared with the no-relapse group, nine patients with multiple (greater than or equal to 3) relapses had longer delays between first symptoms and treatment onset (22 +/- 17 versus 11 +/- 8 wk, p = 0.02), and elevated gamma-glutamyltransferase (124 +/- 98 versus 29 +/- 13 IU/L, p = 0.001) and alkaline phosphatase (190 +/- 124 versus 110 +/- 68 IU/L, p = 0.04) levels. Relapses did not adversely affect outcome. Corticosteroid treatment side effects occurred in 25% of patients. Standardized treatment in 14 patients allowed a reduction of prednisone cumulated doses (p < 0.05) without affecting outcome or relapse rate. We conclude that: (1) delayed treatment increases the risk of relapses; (2) mild cholestasis identifies a subgroup of patients with multiple relapses; (3) relapses do not affect outcome, and prolonged therapy to suppress relapses appears unnecessary; (4) a standardized treatment allows a reduction in steroid doses.
引用
收藏
页码:571 / 577
页数:7
相关论文
共 20 条
[1]   CRYPTOGENIC ORGANIZING PNEUMONIA - A REPORT OF 25 CASES AND A REVIEW OF THE LITERATURE [J].
ALASALY, K ;
MULLER, N ;
OSTROW, DN ;
CHAMPION, P ;
FITZGERALD, JM .
MEDICINE, 1995, 74 (04) :201-211
[2]   PATHOLOGICAL ASPECTS OF BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA [J].
COLBY, TV .
CHEST, 1992, 102 (01) :S38-S43
[3]   IDIOPATHIC BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA - DEFINITION OF CHARACTERISTIC CLINICAL PROFILES IN A SERIES OF 16 PATIENTS [J].
CORDIER, JF ;
LOIRE, R ;
BRUNE, J .
CHEST, 1989, 96 (05) :999-1004
[4]   BOOP IN EUROPE [J].
COSTABEL, U ;
TESCHLER, H ;
SCHOENFELD, B ;
HARTUNG, W ;
NUSCH, A ;
GUZMAN, J ;
GRESCHUCHNA, D ;
KONIETZKO, N .
CHEST, 1992, 102 (01) :S14-S20
[5]   Bronchiolitis obliterans organizing pneumonia syndrome primed by radiation therapy to the breast [J].
Crestani, B ;
Valeyre, D ;
Roden, S ;
Wallaert, B ;
Dalphin, JC ;
Cordier, JF .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 158 (06) :1929-1935
[6]  
DAVISON AG, 1983, Q J MED, V52, P382
[7]  
Epler G R, 1998, Curr Opin Pulm Med, V4, P93, DOI 10.1097/00063198-199803000-00006
[8]   BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA [J].
EPLER, GR ;
COLBY, TV ;
MCLOUD, TC ;
CARRINGTON, CB ;
GAENSLER, EA .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (03) :152-158
[9]  
GUERRYFORCE ML, 1987, AM REV RESPIR DIS, V135, P705
[10]   BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA - CLINICAL-FEATURES AND DIFFERENTIAL-DIAGNOSIS [J].
IZUMI, T ;
KITAICHI, M ;
NISHIMURA, K ;
NAGAI, S .
CHEST, 1992, 102 (03) :715-719